Nanomedicine against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro Evidence

The accumulation of amyloid β (Aβ) triggers a cascade of toxic events in Alzheimer’s disease (AD). The KLVFF peptide can interfere with Aβ aggregation. However, the peptide suffers from poor bioavailability and the inability to cross the blood–brain barrier. In this work, we study the possibility of...

全面介紹

Na minha lista:
書目詳細資料
發表在:Pharmaceutics
Main Authors: Pederzoli, Francesca, Ruozi, Barbara, Duskey, Jason, Hagmeyer, Simone, Sauer, Ann Katrin, Grabrucker, Stefanie, Coelho, Romina, Oddone, Natalia, Ottonelli, Ilaria, Daini, Eleonora, Zoli, Michele, Vandelli, Maria Angela, Tosi, Giovanni, Grabrucker, Andreas M.
格式: Artigo
語言:Inglês
出版: MDPI 2019
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6920811/
https://ncbi.nlm.nih.gov/pubmed/31683907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11110572
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍